JPRN-UMIN000019524已完成未知
Randomized, multicenter, open-label, comparative study on neuroprotective effects of zonisamide (Trerief), anti-parkinsonian drug, in patients with early Parkinson's disease: Evaluation by functional PET (positron emission tomography) images - Trerief Impact in PD PET Study (TIPPS)
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Exclusion criteria are following; 1) Patients with parkinsonism except Parkinson's disease 2) Patients with epilepsy 3) Patients with a history of surgery for PD within 6 months before screening 4) Patients treated with zonisamide, selegiline and/or pramipexole within 3 months before screening 5) Patients with any severe psychiatric symptoms, such as confusion, hallucination, delusion and abnormal behaviors 6) Patients with any histories of malignant syndrome 7) Patients with a history of drug allergy for zonisamide 8) Patients participating any other clinical studies (intervention) when screening 9, 10) Patients evaluated as unsuitable for participation in the study by physicians
研究者
相似试验
进行中（未招募）
不适用
Trerief Impact in PD PET StudyParkinson's diseaseD010300JPRN-jRCTs041180070Ouchi Yasuomi20
尚未招募
3 期
Comparative Study of the Efficacy and Safety of Budesonide, Inhalation Powder, Capsule 400 μg/doseCTRI/2017/02/007787Rus Biopharm LLC136
进行中（未招募）
不适用
An open label, multi-center, randomized, comparative Phase IIIb study to compare efficacy and safety of intravenous (i.v.) daptomycin with that of Semi-synthetic Penicillins (SSPs) or vancomycin in the treatment of elderly patients (aged ≥ 65 years) with complicated Skin and Soft Tissue Infections (cSSTIs) - NDComplicated skin and soft tissue infectionsEUCTR2009-014391-22-ITovartis Pharma AG146
进行中（未招募）
不适用
An open label, multi-center, randomized, comparative Phase IIIb study to compare efficacy and safety of intravenous (i.v.) daptomycin with that of Semi-synthetic Penicillins (SSPs) or vancomycin in the treatment of elderly patients (aged = 65 years) with complicated Skin and Soft Tissue Infections (cSSTIs)complicated skin and soft tissue infections.EUCTR2009-014391-22-DEovartis Pharma AG146
进行中（未招募）
不适用
An open label, multi-center, randomized, comparative Phase IIIb study to compare efficacy and safety of intravenous (i.v.) daptomycin with that of Semi-synthetic Penicillins (SSPs) or vancomycin in the treatment of elderly patients (aged = 65 years) with complicated Skin and Soft Tissue Infections (cSSTIs)complicated skin and soft tissue infections.EUCTR2009-014391-22-ATovartis Pharma Services AG146